Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3)
The summary for the Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3): This NIH Funding Opportunity Announcement (FOA), supported by funds from the NIH Common Fund (Common Fund) and participating NIH Institute(s) and Center(s), invites applications from foreign Institutions in African countries who wish to develop an H3Africa biorepository in order to provide an international site for the receipt, storage and distribution of samples from H3Africa research projects as well as other African genomic research studies. The NIH is partnering with the Wellcome Trust to provide support for H3Africa, an initiative to enhance the development of sustainable research capacity in Africa that will use genomics as a part of a cutting-edge approach to promote health and combat disease. The purpose of this FOA is to call for applications for UH2/UH3 cooperative agreements that will provide funding to develop plans, building upon existing infrastructure, for initial two-year feasibility studies (Phase I) and then for an additional five years of support forfull-scale H3Africa Biorepositories (Phase II), beginning in 2014. The outcome of the feasibility studies will be fully developed plans for up to 3 H3Africa Biorepositories, with evidence that the challenges enumerated below have been overcome.Feasibility testing/planning activities may include testing proposed logistical approaches, training, developing collaborations and otherwise building or planning for additional infrastructure that will be needed for a full-scale repository.
| Federal Grant Title: | Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-RM-12-003 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.172 |
| CFDA Descriptions: | Human Genome Research |
| Current Application Deadline: | Feb 21, 2012 |
| Original Application Deadline: | Feb 21, 2012 |
| Posted Date: | December 21st, 2011 |
| Creation Date: | Dec 21, 2011 |
| Archive Date: | Mar 23, 2012 |
| Total Program Funding: | $400,000 |
| Maximum Federal Grant Award: | $115,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 4 |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); African institutions are eligible for the awards:
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials N...
- • Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, C...
- • Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants ...
- • IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
- • GREGoRi Innovation Projects (U01 Clinical Trial Optional)
- • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
- • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
- • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
- More Grants from the National Institutes of Health
- • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...
- • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
- • Immune Tolerance Network (UM1 Clinical Trial Required)
- • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
- • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
